Abatacept, a recombinant Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) fusion molecule used in RA, has been reported as effective in a Nivolumab-induced MG in an oncologic patient [34]. Here, CTLA4 is linked to rheumatoid arthritis.